ASX - By Stock
|
BOT |
Re:
Ann: Botanix receives A$6.87m R&D Tax Incentive Refund
|
|
Deadlifts
|
56 |
19K |
2 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
56
|
19K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
0 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
1K
|
291K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
6 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
1K
|
291K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix receives A$6.87m R&D Tax Incentive Refund
|
|
Deadlifts
|
56 |
19K |
5 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
56
|
19K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
9 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
1K
|
291K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix receives A$6.87m R&D Tax Incentive Refund
|
|
Deadlifts
|
56 |
19K |
0 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
56
|
19K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix receives A$6.87m R&D Tax Incentive Refund
|
|
Deadlifts
|
56 |
19K |
6 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
56
|
19K
|
6
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Cyber security incident
|
|
Deadlifts
|
106 |
40K |
11 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
106
|
40K
|
11
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Leadership Post CannPal Acquisition
|
|
Deadlifts
|
85 |
32K |
6 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
85
|
32K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
6 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
1K
|
291K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
2 |
06/02/21 |
06/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
0 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
1K
|
291K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
3 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
1K
|
291K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
0 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
291K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
3 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
291K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
9 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
291K
|
9
|
|
ASX - By Stock
|
AGH |
Re:
Peak
|
|
Deadlifts
|
4 |
2.4K |
1 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
4
|
2.4K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Deadlifts
|
1K |
291K |
3 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
291K
|
3
|
|
ASX - By Stock
|
AGH |
Re:
Peak
|
|
Deadlifts
|
4 |
2.4K |
0 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
4
|
2.4K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
GOOD NEWS
|
|
Deadlifts
|
187 |
52K |
3 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
187
|
52K
|
3
|
|
ASX - By Stock
|
SE1 |
Re:
GOOD NEWS
|
|
Deadlifts
|
187 |
52K |
2 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
187
|
52K
|
2
|
|
ASX - By Stock
|
SE1 |
Re:
GOOD NEWS
|
|
Deadlifts
|
187 |
52K |
3 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
187
|
52K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Deadlifts
|
445 |
166K |
0 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
445
|
166K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Deadlifts
|
445 |
166K |
5 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
445
|
166K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Supporting Evidence....!!
|
|
Deadlifts
|
7 |
4.3K |
11 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
7
|
4.3K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Antimicrobial Data Published in Peer-Reviewed Journal
|
|
Deadlifts
|
233 |
84K |
13 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
233
|
84K
|
13
|
|
ASX - By Stock
|
BOT |
Re:
Announcement date and opening price
|
|
Deadlifts
|
370 |
130K |
4 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
370
|
130K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Announcement date and opening price
|
|
Deadlifts
|
370 |
130K |
0 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
370
|
130K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Announcement date and opening price
|
|
Deadlifts
|
370 |
130K |
1 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
370
|
130K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Announcement date and opening price
|
|
Deadlifts
|
370 |
130K |
2 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
370
|
130K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Announcement date and opening price
|
|
Deadlifts
|
370 |
130K |
4 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
370
|
130K
|
4
|
|
ASX - By Stock
|
CPH Medicine |
Re:
Creso Pharma (ASX:CPH) shares up 30pc amid speculation on U.S. cannabis bill
|
|
Deadlifts
|
1.6K |
758K |
0 |
10/01/21 |
10/01/21 |
ASX - By Stock
|
1.6K
|
758K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BTX 1801 is we on the way
|
|
Deadlifts
|
89 |
39K |
9 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
89
|
39K
|
9
|
|
ASX - By Stock
|
AGH |
Re:
Ann: CBD Medicines Available For Over-The-Counter Sale From 2021
|
|
Deadlifts
|
7 |
3.2K |
0 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
7
|
3.2K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: CPH expands foot print in Canada & is now available online
|
|
Deadlifts
|
12 |
5.9K |
3 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
12
|
5.9K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Update on BTX 1801 Phase 2a Clinical Study
|
|
Deadlifts
|
115 |
52K |
4 |
14/12/20 |
14/12/20 |
ASX - By Stock
|
115
|
52K
|
4
|
|
ASX - By Stock
|
CPH |
Re:
the big man is in 21.5 . click and collect
|
|
Deadlifts
|
48 |
24K |
11 |
13/12/20 |
13/12/20 |
ASX - By Stock
|
48
|
24K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Response to ASX Price Query
|
|
Deadlifts
|
16 |
8.4K |
1 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
16
|
8.4K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
Deadlifts
|
62 |
23K |
10 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
62
|
23K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
Deadlifts
|
62 |
23K |
5 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
62
|
23K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
Deadlifts
|
62 |
23K |
4 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
62
|
23K
|
4
|
|
ASX - By Stock
|
BPH |
Re:
Ann: Cortical Patent Application
|
|
Deadlifts
|
15 |
5.1K |
2 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
15
|
5.1K
|
2
|
|
ASX - By Stock
|
BPH |
Re:
Ann: Cortical Patent Application
|
|
Deadlifts
|
15 |
5.1K |
5 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
15
|
5.1K
|
5
|
|
ASX - By Stock
|
BPH |
Re:
Ann: Cortical Patent Application
|
|
Deadlifts
|
15 |
5.1K |
2 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
15
|
5.1K
|
2
|
|
ASX - By Stock
|
BPH |
Re:
Ann: Extension of Voluntary Suspension
|
|
Deadlifts
|
7 |
2.2K |
1 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
7
|
2.2K
|
1
|
|
ASX - By Stock
|
BPH |
Re:
Ann: Extension of Voluntary Suspension
|
|
Deadlifts
|
7 |
2.2K |
0 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
7
|
2.2K
|
0
|
|
ASX - By Stock
|
BPH |
Re:
Ann: Extension of Voluntary Suspension
|
|
Deadlifts
|
34 |
7.1K |
1 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
34
|
7.1K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
Deadlifts
|
46 |
15K |
0 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
46
|
15K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
Deadlifts
|
46 |
15K |
9 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
46
|
15K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Grants BTX 1801 QIDP Designation Status
|
|
Deadlifts
|
91 |
51K |
3 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
91
|
51K
|
3
|
|